NCT00004829View on ClinicalTrials.gov

Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

June 30, 1995

Study Completion Date

May 31, 1998

Conditions

Cystic FibrosisBacterial Infection

Interventions

DRUG

tobramycin

All Listed Sponsors

lead

FDA Office of Orphan Products Development

FED

NCT00004829 - Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter